AHA 2023
Advertisement
Dr. Marc Bonaca discusses the VOYAGER PAD study, which showed the efficacy of rivaroxaban in lower extremity PAD.
Dr. Eugenia Alleva discusses a study that found women with dysmenorrhea have increased cardiovascular risk.
Dr. Benjamin Horne discusses a study that showed increases in PM2.5 during the summer and winter impact heart health.
Dr. Ijeoma Eleazu talks about the harmful impact of cumulative stress on cardiovascular health.
CardioNerds correspondent Dr. Ahmed Ghoneem details the positive effects of semaglutide, as demonstrated in the SELECT trial.
CardioNerds correspondent Dr. Christian Inchaustegui details the findings of ARIES-HM3, presented at AHA 2023.
James K. Min, MD, founder and CEO of Cleerly, talks about improved screening for heart disease using a digital care platform.
Dr. Babak Nazer discusses an experimental, leadless pacemaker that shows great potential in improving patient QoL.
Dr. Karthik Gonuguntla discusses the study he led on cardiovascular health disparities in American Indian adults.
Stenting improves chest pain, exercise capacity, and quality of life among patients with stable chest pain.
A study indicates that blood transfusions for anemic patients hospitalized with heart attack may improve patient outcomes.
COVID-19 infection increases the risk of thromboembolic events, particularly MI, in patients with prior MI.
Elevated lipoprotein(a) increases the risk of major adverse cardiovascular events independent of ASCVD risk scores.
AI and deep learning models may be able to predict the risk of CVD events and valvular heart disease.
630 Madison Ave.
Manalapan, NJ 07726
Connect
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.